Ransomware attack on a healthcare firm slowed clinical trials

Cyberattacks on the healthcare industry are causing more headaches. The New York Times reports that clinical trials slowed down after healthcare software provider eResearchTechnology suffered ransomware attacks starting two weeks ago. IQVIA (a research firm managing AstraZeneca’s COVID-19 vaccine work) and Bristol Myers Squibb (the leader of an alliance developing a fast COVID-19 test) were two of the largest targets.

Both IQVIA and Bristol Myers Squibb said the effect of the attack was “limited,” thanks in part to data backups, but other eResearchTechnology customers apparently had to track trial patients using paper. It’s not clear if the malware affected any COVID-19 trials.